Skip to main content

Table 5 The treatment outcomes in GBS and other bacterial septic arthritis group

From: Group B streptococcus is the most common pathogen for septic arthritis with unique clinical characteristics: data from 12 years retrospective cohort study

Variable All (231) GBS group (87) Other bacterial group (144) P value
Surgery (n, %) 134, 58.0% 54, 62.1% 80, 55.6% 0.331
Complication (n, %) 132, 57.1% 43, 49.4% 89, 61.8% 0.065
Death (n, %) 38, 16.5% 5, 5.7% 33, 22.9% < 0.001
Period of antibiotic treatment
 Total course (days): Median (IQR25-IQR75) 57.0 (42.0–109.0) 60.0 (42.0–143.0) 56.0 (42.0–102.0) 0.287
 Intravenous form (days): Median (IQR25-IQR75) 29.0 (21.0–42.0) 28.0 (19.0–37.0) 30.0 (21.0–45.0) 0.134
 Oral form (days): Median (IQR25-IQR75) 30.0 (8.0–76.0) 34.5 (17.0–98.0) 28.0 (0.0–60.0) 0.007
Length of stay (days): Median (IQR25-IQR75) 29.0 (18.0–42.0) 27.0 (19.0–38.0) 31.0 (18.0–47.0) 0.378
  1. p < 0.05 defined statistical significance, IQR Interquartile range, GBS Streptococcus group B. Complications included sepsis, shock, intubation, admit to intensive unit care, pneumonia, upper urinary tract infection, pressure sore and osteomyelitis